Skip to content
rticc logo
Bruce and Ruth Rappaport Cancer Research Center
  • About
  • Research
  • Members
  • News
  • Join
  • Contact

SUPPORT US
technion logo
D. Dan and Betty Kahn Human Health Building
SUPPORT US
technion logo
D. Dan and Betty Kahn Human Health Building
×
  • About Us
    • Mission and Vision
      • Our History
      • From the Director
    • Leadership & Management
    • Support Us
      • RTICC Supporters
      • Make Your Impact
    • Rappaport-Technion Research Program
    • D. Dan & Betty Kahn Human Health Building
  • Research
    • Cancer Biology
      • The Cancer Cell
      • Cancer Stem Cell
      • Epigenetics & Genomics
      • Metabolism
      • ECM
      • Tumor Microenvironment
      • Cancer Immunology
      • Systems Biology
    • Exact Sciences & Engineering
      • Cancer Chemistry
      • Cancer Biophysics
      • Drug Design
      • Drug Delivery
      • Nanotechnology
      • Imaging
      • Devices
    • Computation & AI
      • Computational Cancer Biology
      • Big Data Analysis
      • Machine Learning
      • AI
    • Translational / Clinical Research
      • Cancer Prevention & Diagnosis
      • Biomarkers
      • Drug Discovery
      • Early Clinical Trials
      • Personalized Medicine
      • Targeted Therapy
    • Core Facilities
      • Biomedical Core Facility
      • ATGC Genomics Center
      • Pre-Clinical Research Authority
      • Perlmutter Metabolomics Center
      • Smoler Protein Research Center
      • LS&E
      • The Russell Berrie NNSCC
    • Funding Opportunities
      • RTICC Fellows
    • Research Initiatives
    • Innovation& Inventions
    • RTICC Resources
  • Members
    • RTICC Members
      • Researchers by Topics
      • A-Z Researchers
      • Faculties & Hospitals
    • Partners & Collaborations
    • External Affiliated Researchers
  • News & Events
    • News
    • Seminars & Events
    • Newsletters
  • Join
    • Careers for Faculty Members
    • Scientific Staff Vacancies
    • Post-Doc & Graduate Students Info
  • Contact Us
  • Support Us

About

  • Mission and Vision
    • Our History
    • From the Director
  • Leadership & Management
  • Support Us
    • RTICC Supporters
    • Make Your Impact
  • Rappaport-Technion Research Program
  • D. Dan & Betty Kahn Human Health Building
  • Mission and Vision
    • Our History
    • From the Director
  • Leadership & Management
  • Support Us
    • RTICC Supporters
    • Make Your Impact
  • Rappaport-Technion Research Program
  • D. Dan & Betty Kahn Human Health Building

Research

  • Cancer Biology
    • Cancer Immunology
    • ECM
    • Metabolism
    • Systems Biology
    • Tumor Microenvironment
    • The Cancer Cell
    • Cancer Stem Cell
    • Epigenetics & Genomics
  • Exact Sciences & Engineering
    • Cancer Biophysics
    • Cancer Chemistry
    • Devices
    • Drug Delivery
    • Drug Design
    • Imaging
    • Nanotechnology
  • Computation & AI
    • AI
    • Big Data Analysis
    • Computational Cancer Biology
    • Machine Learning
  • Translational / Clinical Research
    • Cancer Prevention & Diagnosis
    • Biomarkers
    • Drug Discovery
    • Early Clinical Trials
    • Personalized Medicine
    • Targeted Therapy
  • Core Facilities
    • Biomedical Core Facility
    • ATGC Genomics Center
    • Pre-Clinical Research Authority
    • Perlmutter Metabolomics Center
    • Smoler Protein Research Center
    • LS&E
    • The Russell Berrie NNSCC
  • Funding Opportunities
    • RTICC Fellows
  • Research Initiatives
  • Innovation& Inventions
  • RTICC Cell Lines Database
  • Cancer Biology
    • Cancer Immunology
    • ECM
    • Metabolism
    • Systems Biology
    • Tumor Microenvironment
    • The Cancer Cell
    • Cancer Stem Cell
    • Epigenetics & Genomics
  • Exact Sciences & Engineering
    • Cancer Biophysics
    • Cancer Chemistry
    • Devices
    • Drug Delivery
    • Drug Design
    • Imaging
    • Nanotechnology
  • Computation & AI
    • AI
    • Big Data Analysis
    • Computational Cancer Biology
    • Machine Learning
  • Translational / Clinical Research
    • Cancer Prevention & Diagnosis
    • Biomarkers
    • Drug Discovery
    • Early Clinical Trials
    • Personalized Medicine
    • Targeted Therapy
  • Core Facilities
    • Biomedical Core Facility
    • ATGC Genomics Center
    • Pre-Clinical Research Authority
    • Perlmutter Metabolomics Center
    • Smoler Protein Research Center
    • LS&E
    • The Russell Berrie NNSCC
  • Funding Opportunities
    • RTICC Fellows
  • Research Initiatives
  • Innovation& Inventions
  • RTICC Cell Lines Database

Members

  • RTICC Members
    • Faculty Researchers by Topics
    • A-Z Researchers
    • Faculties & Hospitals
  • Partners & Collaborations
  • External Affiliated Researchers
  • RTICC Members
    • Faculty Researchers by Topics
    • A-Z Researchers
    • Faculties & Hospitals
  • Partners & Collaborations
  • External Affiliated Researchers

News

  • News
    • Newsletters
  • Seminars and Events
  • News
    • Newsletters
  • Seminars and Events

Join

  • Careers for Faculty Members
  • Scientific Staff Vacancies
  • Post-Doc & Graduate Students Info
  • Careers for Faculty Members
  • Scientific Staff Vacancies
  • Post-Doc & Graduate Students Info

Posts Tagged ‘Hereditary cancer syndromes’

Half Elizabeth

Dr. Elizabeth Half, Rambam Health Care Campus

Elizabeth Half
Center for Early Detection and Prevention of Cancer
Rambam Medical Center

Read More

All Tags:

Adaptor proteins (1) Adverse Effects (1) Aging (2) AI (16) Allergy (1) anti-cancer small molecules (1) Antigen Processing and Presentation (1) Apoptosis (1) ARTS (1) Bcl-2 (1) Big Data Analysis (18) Bioethics (1) Biomarkers (25) Biomimetic nanoparticles (1) Brain (1) Breast Cancer (3) Cancer-associated inflammation (2) Cancer Biophysics (9) Cancer Chemistry (7) Cancer Immunology (25) cancer metabolism (1) Cancer Prevention and Diagnosis (25) Cancer Stem Cell (3) Cancer Vaccines (1) Cannabis and Endocannabinoid system (2) Cardiac Remodeling (1) CAR T cells (2) Cell death (2) Cellular Immunotherapy (1) Cellular Networks (1) Chronic Hypertension (1) Computational Cancer Biology (12) Congenital and acquired bone marrow failure (1) Cooperativity in Signaling Complexes (1) Decision-making and Precision Medicine (1) Degradation (1) Devices (8) DNA methylation (1) Drug Delivery (15) Drug Design (11) Drug Discovery (17) Early Clinical Trials (10) ECM (12) Epigenetics & Genomics (24) Ewing Sarcoma (1) Fibrosis (2) Genetics (2) Heart Hypertrophy (1) Hereditary cancer syndromes (1) HLA and MHC peptidomics (1) Imaging (24) Immuno-oncology (3) Immunotherapy (7) Kaposi (1) Lung Cancer (1) Machine Learning (19) Macrophage Polarization (1) Macrophage Reprogramming (1) Metabolism (7) metabolomics (1) Metastasis (4) Microbiome (2) Modeling of Human Disease in Zebrafish and Yeast (1) Molecular Dynamics (1) MRI (4) Nanotechnology (13) Neuroimmunology (2) Nsclc (1) Onconeural Autoimmunity (1) Pediatric Solid Tumors (1) Personalized Medicine (30) Pioneer Factors (1) PROTAC (1) Proteasome (2) Protein Degradation (2) Proteomics (1) Proteomics and PTMs (1) Psychosocial (1) Radiotherapy (1) Regulatory T Cells (2) Researcher (86) Ribosomopathies (1) Sarcoma (1) Single Molecule Resolution (1) Socioeconomic Status (1) Stromal Cells (1) Supportive Care (1) Synthetic Biology (1) System Biology (18) Targeted Therapy (30) T Cell Receptor Signaling (1) The Cancer Cell (31) Toxicity of cancer therapy (1) Tumor-Associated Macrophages (1) Tumor-Progression (1) Tumor Microenvironment (26) Ubiquitin (3) Ubiquitin Ligases (3) VTE (1) XIAP (1)

RTICC - Bruce and Ruth Rappaport Cancer Research Center
technion logo
D. Dan and Betty Kahn Human Health Building white logo

© 2025 RTiCC
Bruce and Ruth Rappaport Cancer Research Center
Accessibility Statement

Scroll To Top